• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物影响下驾驶——口腔液、血清和尿液中药物分析数据的评估以及与损伤症状的相关性

Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.

作者信息

Toennes Stefan W, Kauert Gerold F, Steinmeyer Stefan, Moeller Manfred R

机构信息

Institute of Forensic Toxicology, Center of Legal Medicine, Kennedyallee 104, D-60596 Frankfurt/Main, Germany.

出版信息

Forensic Sci Int. 2005 Sep 10;152(2-3):149-55. doi: 10.1016/j.forsciint.2004.08.002.

DOI:10.1016/j.forsciint.2004.08.002
PMID:15978340
Abstract

A study was performed to acquire urine, serum and oral fluid samples in cases of suspected driving under the influence of drugs of abuse. Oral fluid was collected using a novel sampling/testing device (Dräger DrugTest System). The aim of the study was to evaluate oral fluid and urine as a predictor of blood samples positive for drugs and impairment symptoms. Analysis for cannabinoids, amphetamine and its derivatives, opiates and cocaine was performed in urine using the Mahsan Kombi/DOA4-test, in serum using immunoassay and gas chromatography-mass spectrometry (GC-MS) confirmation and in oral fluid by GC-MS. Police and medical officer observations of impairment symptoms were rated and evaluated using a threshold value for the classification of driving inability. Accuracy in correlating drug detection in oral fluid and serum were >90% for all substances and also >90% in urine and serum except for THC (71.0%). Of the cases with oral fluid positive for any drug 97.1% of corresponding serum samples were also positive for at least one drug; of drug-positive urine samples this were only 82.4%. In 119 of 146 cases, impairment symptoms above threshold were observed (81.5%). Of the cases with drugs detected in serum, 19.1% appeared not impaired which were the same with drug-positive oral fluid while more persons with drug-positive urine samples appeared uninfluenced (32.7%). The data demonstrate that oral fluid is superior to urine in correlating with serum analytical data and impairment symptoms of drivers under the influence of drugs of abuse.

摘要

开展了一项研究,旨在采集疑似药物滥用影响下驾驶案例的尿液、血清和口腔液样本。使用一种新型采样/检测设备(德尔格药物检测系统)采集口腔液。该研究的目的是评估口腔液和尿液作为药物阳性血样及损伤症状预测指标的情况。使用Mahsan Kombi/DOA4检测法对尿液中的大麻素、苯丙胺及其衍生物、阿片类药物和可卡因进行分析,血清分析采用免疫测定法并通过气相色谱 - 质谱联用(GC - MS)进行确证,口腔液则通过GC - MS进行分析。警察和医务人员对损伤症状的观察结果采用驾驶能力分类阈值进行评分和评估。口腔液和血清中药物检测的相关性准确率对于所有物质均>90%,尿液和血清的相关性准确率除四氢大麻酚(THC,71.0%)外也>90%。在口腔液中任何药物呈阳性的案例中,97.1%的相应血清样本中至少有一种药物也呈阳性;而在药物阳性的尿液样本中,这一比例仅为82.4%。在146个案例中的119个(81.5%)观察到了高于阈值的损伤症状。在血清中检测出药物的案例中,19.1%的人似乎未受影响,药物阳性口腔液的情况也是如此,而药物阳性尿液样本中更多人似乎未受影响(32.7%)。数据表明,在与药物滥用影响下驾驶员的血清分析数据和损伤症状的相关性方面,口腔液优于尿液。

相似文献

1
Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.药物影响下驾驶——口腔液、血清和尿液中药物分析数据的评估以及与损伤症状的相关性
Forensic Sci Int. 2005 Sep 10;152(2-3):149-55. doi: 10.1016/j.forsciint.2004.08.002.
2
Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.路边口腔液检测:Drugwipe 5和Drugwipe苯二氮䓬类药物现场检测结果与口腔液和全血实验室确认结果的比较。
Forensic Sci Int. 2008 Mar 5;175(2-3):140-8. doi: 10.1016/j.forsciint.2007.05.022. Epub 2007 Jul 20.
3
On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".非法药物的现场检测:使用药物检测设备“Toxiquick”
Forensic Sci Int. 2004 Jun 30;143(1):21-5. doi: 10.1016/j.forsciint.2004.01.013.
4
Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.通过液相色谱-质谱联用技术对路边检测获得的口腔液中的药物进行确证。
Forensic Sci Int. 2007 Aug 6;170(2-3):156-62. doi: 10.1016/j.forsciint.2007.03.034. Epub 2007 Jul 20.
5
The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.使用口腔液和汗液擦拭物检测驾驶员滥用药物的情况。
J Forensic Sci. 2002 Nov;47(6):1380-7.
6
Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.同时采集的挪威毒驾者的唾液、尿液和血液中滥用药物的检测。
Forensic Sci Int. 2012 Jun 10;219(1-3):165-71. doi: 10.1016/j.forsciint.2012.01.001. Epub 2012 Jan 30.
7
Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.采用液相色谱-串联质谱法测定受损驾驶员口腔液和血浆中Δ9-四氢大麻酚浓度的相关性及现场德格医用毒品检测评估。
Forensic Sci Int. 2006 Sep 12;161(2-3):175-9. doi: 10.1016/j.forsciint.2006.03.033. Epub 2006 Jul 13.
8
First nationwide study on driving under the influence of drugs in Switzerland.瑞士首次全国范围内的药物影响下驾驶研究。
Forensic Sci Int. 2010 May 20;198(1-3):11-6. doi: 10.1016/j.forsciint.2010.02.014. Epub 2010 Mar 7.
9
Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid.用于检测口腔液中阿片类药物和可卡因的Cozart RapiScan药物检测系统的评估。
Forensic Sci Int. 2005 Jun 10;150(2-3):239-43. doi: 10.1016/j.forsciint.2004.12.042. Epub 2005 Apr 15.
10
Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.在疑似药物滥用影响下驾驶的驾驶员中,口腔液和血液中滥用药物浓度之间的关系。
Ther Drug Monit. 2009 Aug;31(4):511-9. doi: 10.1097/FTD.0b013e3181ae46ea.

引用本文的文献

1
Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device.在口腔液样本中检测大麻素作为即时检测生物传感器诊断设备的首选生物基质。
Biosensors (Basel). 2024 Feb 27;14(3):126. doi: 10.3390/bios14030126.
2
Intrauterine and Neonatal Exposure to Opioids: Toxicological, Clinical, and Medico-Legal Issues.宫内及新生儿期阿片类药物暴露:毒理学、临床及法医学问题
Toxics. 2023 Jan 9;11(1):62. doi: 10.3390/toxics11010062.
3
Randomly controlled drivers using minimally invasive sampling: assessment of drug prevalence in Western Switzerland over two time periods.
随机对照驾驶员使用微创采样:对瑞士西部两个时期药物流行情况的评估。
BMC Public Health. 2022 Dec 28;22(1):2446. doi: 10.1186/s12889-022-14883-2.
4
Use of a Novel EEG-Based Objective Test, the Cognalyzer, in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework.在一项观察性研究框架内,使用基于脑电图的新型客观测试工具Cognalyzer来量化大麻精神活性作用的强度、确定其作用时间以及可能影响这些作用的因素。
Neurol Ther. 2022 Mar;11(1):51-72. doi: 10.1007/s40120-021-00293-w. Epub 2021 Nov 2.
5
Sensitivity, Specificity and Accuracy of a Novel EEG-Based Objective Test, the Cognalyzer, in Detecting Cannabis Psychoactive Effects.新型基于脑电图的客观测试,即 Cognalyzer,在检测大麻精神活性效应中的敏感性、特异性和准确性。
Adv Ther. 2021 May;38(5):2513-2531. doi: 10.1007/s12325-021-01718-6. Epub 2021 Apr 7.
6
Psychoactive drug consumption among truck-drivers: a systematic review of the literature with meta-analysis and meta-regression.卡车司机使用精神活性药物情况:一项包含荟萃分析和元回归的文献系统综述
J Prev Med Hyg. 2019 Jun 28;60(2):E124-E139. doi: 10.15167/2421-4248/jpmh2019.60.2.1245. eCollection 2019 Jun.
7
Occupational health and safety of road haulage company employees.道路货运公司员工的职业健康与安全。
Med Lav. 2018 May 28;109(3):180-9. doi: 10.23749/mdl.v109i3.6827.
8
Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs.血液和口腔液中精神活性药物浓度与药物影响下驾驶认知障碍的相关性。
Curr Neuropharmacol. 2018;16(1):84-96. doi: 10.2174/1570159X15666170828162057.
9
Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.静脉注射可卡因受控给药后口腔液中可卡因和苯甲酰爱康宁的浓度。
Forensic Sci Int. 2016 Mar;260:95-101. doi: 10.1016/j.forsciint.2016.01.013. Epub 2016 Jan 22.
10
Cannabis Smoking in 2015: A Concern for Lung Health?2015年吸食大麻:对肺部健康构成威胁?
Chest. 2015 Sep;148(3):596-606. doi: 10.1378/chest.15-0447.